ARTICLE | Distillery Therapeutics
Inhibiting the PYK2-IRF5 axis for ulcerative colitis
January 7, 2022 10:21 PM UTC
DISEASE CATEGORY: Autoimmune
INDICATION: Inflammatory bowel disease...
BCIQ Company Profiles
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
DISEASE CATEGORY: Autoimmune
INDICATION: Inflammatory bowel disease...
BCIQ Company Profiles
BCIQ Company Profiles